Clinical Trials Directory

Trials / Sponsors / Biotie Therapies Inc.

Biotie Therapies Inc.

Industry · 10 registered clinical trials.

StatusTrialPhaseStarted
TerminatedA Study to Determine the Abuse Potential of Tozadenant Relative to D-Amphetamine and Placebo When Administered
Abuse Potential
Phase 12017-09-18
TerminatedStudy to Investigate the Influence of Hepatic Insufficiency on the Pharmacokinetics of Tozadenant
Hepatic Impairment
Phase 12017-06-30
TerminatedSafety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Dise
Idiopathic Parkinson Disease
Phase 32017-04-10
TerminatedSafety and Efficacy Study of Tozadenant to Treat End of Dose Wearing Off in Parkinson's Patients
Idiopathic Parkinson's Disease
Phase 32015-07-01
CompletedSYN120 Study to Evaluate Its Safety, Tolerability and Efficacy in Parkinson's Disease Dementia (SYNAPSE)
Parkinson's Disease Dementia (PDD)
Phase 22014-12-22
CompletedStudy to Evaluate the Absorption, Distribution, Break Down and Elimination and the Safety of 14C-Labeled Tozad
N/A, as Healthy Volunteers
Phase 12013-09-01
CompletedSafety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Parkinson's Disease
Phase 2 / Phase 32011-03-01
CompletedStudy of Safety and Potential Efficacy of SYN117 in Cocaine Dependent Volunteers
Cocaine Dependence
Phase 1 / Phase 22008-06-01
CompletedStudy to Evaluate SYN115 in Parkinson's Disease
Parkinson's Disease
Phase 22008-04-01
CompletedExploratory Study to Evaluate the Effect of SYN111 (Rufinamide) in Patients With Generalized Anxiety Disorder
Generalized Anxiety Disorder
Phase 22008-03-01